Willow Biosciences Inc WLLW

TOR: WLLW | ISIN: CA97111B4047   10/05/2024
0,090 CAD (0,00%)
(0,00%)   10/05/2024

29 maart 2024 · Willow Biosciences Reports Fourth Quarter And Fiscal Year 2023 Financials And Operations And Filing Of Its 2023 Aif · Persbericht

1 maart 2024 · Willow Biosciences Announces Second Strategic Investment From Kalsec · Persbericht

21 februari 2024 · Willow Biosciences Announces Strategic Investment From Kalsec To Develop Innovative Natural Food Ingredients · Persbericht

31 januari 2024 · Willow Announces Collaboration With Global Ingredient Manufacturer To Develop A More Cost-Effective, Sustainable Process For A Large Volume Active Pharmaceutical Ingredient · Persbericht

16 januari 2024 · Willow Announces Collaboration With Enterin To Develop Sustainable Intermediates And Active Pharmaceutical Ingredients · Persbericht

10 januari 2024 · Willow Plans For Significant Growth In 2024 On The Back Of A Successful 2023 · Persbericht

7 december 2023 · Willow And Leading Innovative Biopharmaceutical Company Advance Development Program To Manufacture Sustainable Intermediates And Active Pharmaceutical Ingredients · Persbericht

11 oktober 2023 · Willow Biosciences Announces Completion Of Previously Announced Convertible Debenture Financing · Persbericht

3 oktober 2023 · Willow And Suanfarma Announce Collaboration On Development Of Large Volume Anti-Infective Api Through Precision Fermentation · Persbericht

3 oktober 2023 · Willow Et Suanfarma Annoncent Leur Collaboration Pour Le Développement D'un Grand Volume D'api Anti-Infectieux Par Le Biais De La Fermentation De Précision · Persbericht

6 september 2023 · WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCA · Persbericht

30 augustus 2023 · Willow Announces Filing Of Patent Application For Process To Produce Corticosteroids At Signficantly Reduced Cost · Persbericht

24 augustus 2023 · Willow Biosciences Announces Commercial Transition And Focus On Biooxi Platform · Persbericht

21 augustus 2023 · Willow Announces Collaboration With A Leading Innovative Biopharmaceutical Company To Develop Sustainable Intermediates And Active Pharmaceutical Ingredients · Persbericht

8 augustus 2023 · Willow Biosciences Reports Second Quarter 2023 Financial Results · Persbericht

2 augustus 2023 · Willow Biosciences To Present At The Emerging Growth Conference On August 9 · Persbericht

20 juli 2023 · Willow And Kalsec Advance Development Program For New Natural Functional Ingredient For Savory Foods · Persbericht

7 juni 2023 · Willow Biosciences To Present At The Emerging Growth Conference On June 14 · Persbericht

31 mei 2023 · Willow Signs Master Services Agreement With Innovative Biotech Company To Develop Ingredients For Age-Related Diseases · Persbericht

23 mei 2023 · Kalsec And Willow Biosciences To Develop Novel Enzyme For Production Of An Advanced Beverage Ingredient · Persbericht

Mijn selecties